Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-12-24Clinical Trial Update: Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy [Phase 2]
Phase 2 trial evaluating continuous positive airway pressure to manage tumor motion during radiotherapy in lung, breast, and abdominal cance…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating BAY59-8862 in taxane-resistant metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated the combination of RO4929097, a gamma-secretase inhibitor, with Cediranib maleate in adults with advanced solid…
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients
Clinical trial update examining uterine cavity assessment and endometrial gene expression in women with breast cancer treated with tamoxifen…
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Partial Breast Irradiation With Interstitial High Dose Rate Brachytherapy [Phase 2]
Phase 2 clinical trial evaluating partial breast irradiation with interstitial high-dose-rate brachytherapy for breast cancer. Current statu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-12-22FDA Approved: TYKERB — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tykerb (lapatinib) submitted by Novartis Pharmaceuticals Corporation. The approval pertains to a…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial results for Paclitaxel plus Bevacizumab, with or without Everolimus, in HER2-negative metastatic breast cancer have been compl…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial evaluating ixabepilone with carboplatin and trastuzumab in HER2-positive locally advanced breast cancer has comp…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer [Phase 1, Phase 2]
Phase I/II clinical trial evaluating the combination of sorafenib and ixabepilone in HER2-negative metastatic breast cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases [Phase 2]
Phase 2 trial update of Yttrium-90 glass microsphere radioembolization (TheraSphere) for patients with liver metastases, completed with resu…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Participation Restrictions in Breast Cancer Survivors [NA]
This is an update on a completed clinical trial. It describes participation restrictions for breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC [Phase 2]
Phase 2 neoadjuvant trial evaluating FEC chemotherapy with G-CSF support followed by ixabepilone with G-CSF support in breast cancer; the st…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. [Phase 2]
Phase 2 study evaluating trastuzumab in combination with capecitabine in patients with HER2-positive metastatic or recurrent breast cancer a…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer. [Phase 2]
Phase 2 trial update evaluating the combination of lapatinib and capecitabine in patients aged 70 and older with HER2-positive metastatic br…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Phase 3]
A Phase 3 trial comparing high-dose chemotherapy with peripheral stem cell transplantation to standard therapy in women with locally recurre…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
An update on a completed clinical trial evaluating cognitive difficulties (chemo brain) and quality of life in women with breast cancer unde…
-
CLINICAL_TRIALS research · 2014-12-16Clinical Trial Update: Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy [NA]
A completed clinical trial evaluating the use of PET imaging with the radiotracer 18F-fluorothymidine (FLT) to treat women with locally adva…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating combination chemotherapy versus observation after surgery in women with relapsed nonmetastatic breast cancer has …
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating panitumumab with gemcitabine and carboplatin in metastatic triple-negative breast cancer; the study has been comple…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating Abraxane plus carboplatin as first-line therapy for triple-negative metastatic breast cancer was terminated; result…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)
This clinical trial update reports results from a Phase I study of computed optical margin assessment in breast cancer surgery. The results …
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography [EARLY_Phase 1]
Early-phase (Phase 1) clinical trial evaluating the copper-64 radiotracer 64Cu-DOTA-AE105 for diagnosing aggressive cancers with PET; the st…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Gentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla [Phase 3]
A Phase 3 randomized trial comparing gentamicin lavage to clindamycin lavage and normal saline lavage in the axilla for breast cancer has co…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer [Phase 2]
A Phase 2 trial evaluating the feasibility and optimal sequencing of postoperative adjuvant FEC (fluorouracil, epirubicin, cyclophosphamide)…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Caelyx Adjuvant in Elderly Breast Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating Caelyx (pegylated liposomal doxorubicin) as adjuvant therapy in elderly patients with bre…